GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Interest Expense

ACHKF (Achiko AG) Interest Expense : $-0.83 Mil (TTM As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Achiko AG's interest expense for the six months ended in Jun. 2022 was $ -0.52 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2022 was $-0.83 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Achiko AG's Operating Income for the six months ended in Jun. 2022 was $ -1.92 Mil. Achiko AG's Interest Expense for the six months ended in Jun. 2022 was $ -0.52 Mil. Achiko AG did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Achiko AG Interest Expense Historical Data

The historical data trend for Achiko AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Interest Expense Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
Interest Expense
- -0.62 -0.03 -0.62

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Interest Expense Get a 7-Day Free Trial -0.18 -0.03 -0.30 -0.32 -0.52

Achiko AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Achiko AG  (OTCPK:ACHKF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Achiko AG's Interest Expense for the six months ended in Jun. 2022 was $-0.52 Mil. Its Operating Income for the six months ended in Jun. 2022 was $-1.92 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2022 was $3.56 Mil.

Achiko AG's Interest Coverage for the quarter that ended in Jun. 2022 is calculated as

Achiko AG did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Achiko AG Business Description

Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.